| 注册
首页|期刊导航|中国医学创新|鼻咽癌放疗后残留的研究进展

鼻咽癌放疗后残留的研究进展

廖平燕 梁华震 习荣亮 黄国森

中国医学创新2024,Vol.21Issue(1):165-170,6.
中国医学创新2024,Vol.21Issue(1):165-170,6.DOI:10.3969/j.issn.1674-4985.2024.01.039

鼻咽癌放疗后残留的研究进展

Research Progress of Residual Nasopharyngeal Carcinoma after Radiotherapy

廖平燕 1梁华震 2习荣亮 3黄国森1

作者信息

  • 1. 广州中医药大学附属中山中医院放疗科 广东 中山 528400
  • 2. 茂名市人民医院肿瘤科 广东 茂名 525099
  • 3. 广州艾维迪生物技术有限公司 广东 广州 511449
  • 折叠

摘要

Abstract

Nasopharyngeal carcinoma(NPC)is a common malignant tumor of head and neck in China,which has a high incidence in South China,especially in Guangdong Province,also known as"Guangdong cancer".Because of the special anatomical location and good radiosensitivity of nasopharynx,radiotherapy has become the main treatment of nasopharyngeal carcinoma.However,tumor residues often occur in patients with nasopharyngeal carcinoma after radiotherapy.At present,there is still a lot of controversy about the diagnosis,treatment and the effect of tumor residue on prognosis.For the diagnosis of tumor residue,there are many ways,such as a variety of different imaging,histopathological biopsy,etc.We should give full play to the advantages of various examination methods to improve the accuracy of diagnosis.On the other hand,it is necessary to determine tumor residue in a timely and effective manner to avoid missing the best opportunity for intervention.For the treatment of residual lesions,it is necessary to formulate treatment strategies based on the location,size and infiltration range of the lesions.Multiple previous studies have shown that patients with tumor residue have a worse prognosis.This article reviews the research on the tumor residue of nasopharyngeal carcinoma after radiotherapy.

关键词

鼻咽癌/肿瘤残留/放疗

Key words

Nasopharyngeal carcinoma/Tumor residue/Radiotherapy

引用本文复制引用

廖平燕,梁华震,习荣亮,黄国森..鼻咽癌放疗后残留的研究进展[J].中国医学创新,2024,21(1):165-170,6.

中国医学创新

1674-4985

访问量2
|
下载量0
段落导航相关论文